Clayton E W, Steinberg K K, Khoury M J, Thomson E, Andrews L, Kahn M J, Kopelman L M, Weiss J O
Department of Pediatrics, Vanderbilt University, Nashville, Tenn, USA.
JAMA. 1995 Dec 13;274(22):1786-92.
To develop recommendations for obtaining adequate informed consent in the future when gathering tissue samples that may be used for genetic studies and defining the circumstances under which it is necessary to obtain further consent if tissue samples already in hand are to be used for such research.
Scientists, ethicists, lawyers, and consumers selected by the National Center for Human Genome Research and the Centers for Disease Control and Prevention to represent a wide array of opinions.
Statutes, regulations, and cases and articles on law and ethics.
Initial workshop, followed by circulation of several drafts of this document with opportunities for comment by workshop participants and others as well as smaller meetings involving participants with widely differing views.
Genetic research using stored tissue samples poses an array of benefits and risks to individuals, researchers, and society. As a result, the workshop participants conclude that (1) informed consent is required for all genetic research using linkable samples unless conditions for limitation or waiver are met; (2) informed consent is not required for genetic research using anonymous samples but may be considered if identifiers are to be removed from currently linkable samples; (3) institutional review boards could usefully review all protocols that propose to use samples for genetic research; and (4) further work regarding these issues is warranted.
就未来在收集可能用于基因研究的组织样本时获得充分知情同意提出建议,并明确在何种情况下,如果要将已有的组织样本用于此类研究,有必要获取进一步的同意。
由国家人类基因组研究中心和疾病控制与预防中心挑选的科学家、伦理学家、律师和消费者,以代表广泛的意见。
法规、条例以及关于法律和伦理的案例与文章。
举办初始研讨会,随后分发本文件的多个草稿,供研讨会参与者及其他人员发表意见,并召开涉及观点差异较大的参与者的小型会议。
使用储存的组织样本进行基因研究给个人、研究人员和社会带来一系列益处和风险。因此,研讨会参与者得出以下结论:(1)除非满足限制或豁免条件,否则所有使用可关联样本的基因研究都需要知情同意;(2)使用匿名样本的基因研究不需要知情同意,但如果要从当前可关联样本中去除标识符,则可以考虑获取知情同意;(3)机构审查委员会可以有效地审查所有提议将样本用于基因研究的方案;(4)有必要就这些问题开展进一步的工作。